Sarah Elizabeth Williams | Mount Sinai

About Me

Sarah is a Ph.D. candidate in the department of Neuroscience, co-mentored by Dr. Kristen Brennand of Yale University. Her research utilizes human stem cell models to study genetic risk for psychiatric disorders, with an emphasis on cell-type-specific effects, non-coding variants, and multiplexing strategies. Before coming to Sinai in 2020, Sarah completed her B.S. in Biochemistry with a minor in Behavioral Neuroscience at Northeastern University. While in Boston, she worked under Drs. Jordan Smoller and Richard Cummings as a research technician studying the role of glycosylation in schizophrenia biology through the lens of common genetic variation.

https://orcid.org/0000-0003-3624-611X

Language

English

Position

GRADUATE STUDENT | Graduate Students

Research Topics

Autism, Epigenetics, Genomics, Neuroscience, Reprogramming, Schizophrenia, Stem Cells

Multi-Disciplinary Training Areas

Neuroscience [NEU]

Education

BS, Northeastern University

PhD, Icahn School of Medicine at Mount Sinai

Locations

Icahn (East) Building Floor 13 Room 52, 1425 Madison Ave, New York, NY, 10029

508-212-5699

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. WILLIAMS has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.